Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07811180
NA

Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells - Intensive Care Unit

Sponsor: Vanderbilt University Medical Center

View on ClinicalTrials.gov

Summary

The purpose of this study is to understand how cells of the immune system use the common sugar glucose during critical illness. Investigators will intravenously infuse a non-radioactive carbon-13 glucose tracer into adult intensive care unit (ICU) participants over a few hours and collect immune cells from the blood to track uptake and usage of this glucose within these immune cells.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2026-11-01

Completion Date

2028-03-01

Last Updated

2026-09-09

Healthy Volunteers

No

Interventions

DRUG

13C6-Glucose

Compounded as 5% 13C6-glucose in water and given intravenously over 2-4 hours at a total dose of 10-25 grams.

Locations (1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States